(Q39734632)

14 September 2017

Possible role of 5-hydroxytryptamine in minimal brain dysfunction (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

2 May 2022

Possible role of 5-hydroxyptamine in minimal brain dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A124375

2 May 2022

author name string

D. A. Brase

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A124375

2 May 2022

H. H. Loh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A124375

2 May 2022

language of work or name

English

0 references

publication date

1 April 1975

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0024320575901848?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

https://api.elsevier.com/content/article/PII:0024320575901848?httpAccept=text/plain

2 May 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

2 May 2022

1 reference

14 September 2017

16

1 reference

14 September 2017

7

1 reference

14 September 2017

1005-1015

1 reference

Some speculations concerning a possible biochemical basis of minimal brain dysfunction

14 September 2017

1

14

1605

Wender

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

The Syndrome of Minimal Brain Damage in Childhood

2 May 2022

2

275

27

Pincus

1966

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.

2 May 2022

5

155

55

Wender

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

How amphetamine acts in minimal brain dysfunction

2 May 2022

6

205

310

Snyder

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Release of norepinephrine from hypothalamus and amygdala by rewarding medial forebrain bundle stimulation and amphetamine.

2 May 2022

7

67

189

Stein

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Facilitation of Brain Self-Stimulation by Central Administration of Norepinephrine

2 May 2022

8

163

299

Wise

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain

2 May 2022

10

28

295

Taylor

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms

2 May 2022

11

27

816

Arnold

0 references

Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues

14

12

669

Harris

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

2 May 2022

17

20

140

Carlsson

1963

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs.

2 May 2022

18

4

395

Nyback

1968

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

2 May 2022

20

11

303

Anden

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities

2 May 2022

21

14

767

Millichap

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Haloperidol in the Treatment of Children with Severe Behaviour Disorders

2 May 2022

22

114

845

Cunningham

1968

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

A Controlled Trial of Haloperidol in Children

2 May 2022

23

114

855

Barker

1968

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Brain serotonin content: physiological dependence on plasma tryptophan levels.

2 May 2022

26

173

149

Fernstrom

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

BEHAVIOUR OF RATS DEPLETED OF 5-HYDROXYTRYPTAMINE BY FEEDING A DIET FREE OF TRYPTOPHAN

2 May 2022

30

5

28

Boullin

1963

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effect of Chronic Corn Consumption on Serotonin Content of Rat Brain

2 May 2022

31

234

62

Fernstrom

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

2 May 2022

Molecular Pharmacology

33

3

274

Jequier

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

A possible role for 5-hydroxytryptamine in drug-induced seizures.

2 May 2022

35

22

858

De La Torre

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Hyperkinetic impulse disorder in children's behavior problems.

2 May 2022

37

19

38

Laufer

0 references

The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat

38

10

204

Tenen

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

The effects of p-chlorophenylalanine on experimentally induced conflict in the rat

2 May 2022

39

8

965

Robichaud

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

The effects of p-chlorophenylalanine, a depletor of brain serotonin, on behavior: II. Retardation of passive avoidance learning

2 May 2022

40

8

379

Stevens

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior.

2 May 2022

41

9

319

Gellfr

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

A characteristic form of overactive behaviour in brain damaged children.

2 May 2022

43

102

550

Ingram

1956

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effects of dextroamphetamine sulfate on EEG sleep patterns of hyperactive children

2 May 2022

44

25

369

Small

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Platelet-serotonin level in children with "minimal brain dysfunction".

2 May 2022

48

ii

1012

Wender

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Serotonin concentrations in whole blood of hyperactive children

2 May 2022

49

78

985

Coleman

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin

2 May 2022

51

22

967

Lott

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Phenylketonuria. II. Results of treatment of infants and young children. A report of 10 cases

2 May 2022

55

59

102

Centerwall

1961

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Comparison of Effects of LSD and Amphetamine on Midbrain Raphe Units

2 May 2022

57

222

567

Foote

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effect of four amphetamines on brain biogenic amines and their metabolites.

2 May 2022

61

21

1289

Leonard

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Serotonergic inhibition of catecholamine-induced behavioral arousal.

2 May 2022

65

49

381

Mabry

0 references

Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine

66

52

307

Breese

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions

2 May 2022

67

9

655

Neill

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin

2 May 2022

68

14

124

Chrusciel

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effects of cocaine and amphetamine on the metabolism of tryptophan and 5-hydroxytryptamine in mouse brain in vivo.

2 May 2022

70

22

860

Schubert

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Effect of amphetamines on tryptophan concentrations in mice and rats.

2 May 2022

71

24

53

Schubert

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats

2 May 2022

74

36

189

Scheel-Kruger

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Caffeine as a Substitute for Schedule II Stimulants in Hyperkinetic Children

2 May 2022

76

130

796

Schnackenberg

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Anorexigenic drugs and lipid mobilisation

2 May 2022

77

17

596

Santi

1965

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Response of free fatty acids to coffee and caffeine

2 May 2022

78

17

702

Bellet

1968

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

Studies on the mechanism of amphetamine-induced lipolysis in the rat

2 May 2022

80

19

98

Shaw

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

A note on the effect of (+)- and (-)-amphetamine on lipid metabolism.

2 May 2022

81

25

418

Hajos

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90184-8

2 May 2022

Identifiers

1 reference

14 September 2017

1 reference